Intra-abdominal fat cells may contribute to the development and progression of inflammatory bowel disease (IBD), according to a study1 published in Cellular and Molecular Gastroenterology and ...

Please provide your email address to receive an email when new articles are posted on . Emblaveo is the first monobactam/beta-lactamase inhibitor and antibiotic combination approved for this condition ...

In a randomised controlled trial (RCT) in adults with complicated intra‑abdominal infections, intravenous ceftolozane/tazobactam plus metronidazole was found to be ...

Children whose appendix has burst often develop serious abdominal infections that are hard to treat and increasingly ...

What is Abdominal Compartment Syndrome? Abdominal compartment syndrome is defined as an intra-abdominal pressure of more than 20 mm Hg that results in the failure of an organ like the kidney or the ...

The Surgical Infection Society (SIS) presents new evidence-based guidelines for the management of intra-abdominal infection (IAI) in the journal Surgical Infections. "These guidelines are critical in ...

Please provide your email address to receive an email when new articles are posted on . Advancements in imaging, risk stratification and antimicrobial stewardship are reflected in new guidelines for ...

Delivering high-quality emergency care for kids may mean fewer CT scans, according to a new study. The research validates intra-abdominal injury (IAI) and traumatic brain injury (TBI) prediction rules ...

For the first time since 2010, the Infectious Disease Society of America published new guidelines for treating complex abdominal infections. The revisions were prompted by “significant morbidity and ...

Emblaveo marks the first and only fixed-dose intravenous monobactam/β-lactamase inhibitor combination antibiotic to be approved by the FDA for complicated intra-abdominal infections with limited ...